NCT04743661 2026-02-05131I-Omburtamab, in Recurrent Medulloblastoma and EpendymomaPediatric Brain Tumor ConsortiumPhase 2 Active not recruiting62 enrolled
NCT00138216 2023-10-02Temozolomide, Vincristine, and Irinotecan in Treating Young Patients With Refractory Solid TumorsChildren's Oncology GroupPhase 1 Completed42 enrolled